Citigroup Inc Sutro Biopharma, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Citigroup Inc holds 61,140 shares of STRO stock, worth $113,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,140

Previous 19,189 218.62%

Holding current value

$113,109

Previous $56,000 276.79%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.88 - $5.01 $120,818 - $210,174	41,951 Added 218.62%	61,140 $211,000
Q2 2024 Aug 12, 2024	BUY	$2.92 - $5.33 $22,209 - $40,539	7,606 Added 65.67%	19,189 $56,000
Q1 2024 May 10, 2024	BUY	$3.27 - $5.65 $9,515 - $16,441	2,910 Added 33.55%	11,583 $65,000
Q4 2023 Feb 09, 2024	BUY	$2.07 - $4.54 $16,245 - $35,629	7,848 Added 951.27%	8,673 $37,000
Q3 2023 Nov 09, 2023	SELL	$3.29 - $4.9 $59,726 - $88,954	-18,154 Reduced 95.65%	825 $2,000
Q2 2023 Aug 10, 2023	SELL	$4.25 - $5.88 $650,896 - $900,533	-153,152 Reduced 88.97%	18,979 $88,000
Q1 2023 May 11, 2023	BUY	$4.48 - $8.45 $575,397 - $1.09 Million	128,437 Added 293.95%	172,131 $795,000
Q4 2022 Feb 09, 2023	BUY	$5.41 - $8.08 $229,373 - $342,575	42,398 Added 3271.45%	43,694 $353,000
Q3 2022 Nov 10, 2022	SELL	$5.17 - $7.11 $13,664 - $18,791	-2,643 Reduced 67.1%	1,296 $7,000
Q2 2022 Aug 10, 2022	SELL	$3.41 - $8.95 $84,336 - $221,351	-24,732 Reduced 86.26%	3,939 $21,000
Q1 2022 May 12, 2022	SELL	$7.78 - $15.31 $344,428 - $677,789	-44,271 Reduced 60.69%	28,671 $236,000
Q4 2021 Feb 10, 2022	BUY	$14.25 - $23.53 $433,727 - $716,182	30,437 Added 71.61%	72,942 $1.09 Million
Q3 2021 Nov 10, 2021	BUY	$16.88 - $22.38 $717,484 - $951,261	42,505 New	42,505 $803,000

Others Institutions Holding STRO

# of Institutions

137

Shares Held

62.4M

Call Options Held

77.1K

Put Options Held

31.4K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $96.5M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account